; CURRICULUM VITAE David D. Dore_
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out
Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

CURRICULUM VITAE David D. Dore_

VIEWS: 33 PAGES: 9

  • pg 1
									                                  CURRICULUM VITAE
                               David D. Dore, PharmD, PhD


CONTACT INFORMATION

Office:        i3 Drug Safety
               950 Winter Street, Suite 3800
               Waltham, MA 02451
               Tel: 781-472-8497
               Fax: 781-472-8464
               david.dore@i3drugsafety.com
               david_dore@brown.edu


EDUCATION

2008           PhD, Epidemiology (Advisor: Kate L. Lapane, PhD)
               Brown Medical School, Providence, RI

2006−2007      Post-doctoral Fellowship (Mentor: Vincent Mor, PhD)
               Center for Gerontology and Health Care Research
               Brown Medical School, Providence, RI

2004           PharmD
               University of Rhode Island, Kingston, RI


PROFESSIONAL EXPERIENCE

2010−Present          Senior Scientist (Epidemiology)
                      i3 Drug Safety, Waltham, MA
                      • Oversight and management of epidemiologic studies
                      • Interpreting study results
                      • Development and review of study protocols, reports, and
                          manuscripts for publication
                      • Client interaction
                      • Proposal development and study design
                      • Development of capabilities and scientific direction of the group
                      • Mentoring junior epidemiologists
                      • Formal consulting with external clients
                      • Managing direct reports

2007−2010             Epidemiologist III (Senior Epidemiologist)
                      i3 Drug Safety, Waltham, MA
                      Responsibilities included:
                      • Oversight and management of epidemiologic studies
                      • Interpreting study results
                      • Writing study protocols, reports, and manuscripts for publication
                      • Client interaction


Updated May 2010                                                               Page 1 of 9
                   •   Proposal development and study design
                   •   Development of capabilities
                   •   Formal consulting with external clients

2008−present       Adjunct Assistant Professor of Community Health
                   Department of Community Health
                   The Warren Alpert Medical School of Brown University
                   Providence, RI

2007               Consultant, Pharmacoepidemiology
                   i3 Drug Safety, Waltham, MA
                   Responsible for supporting project team in preparing study protocols
                   and reports

2006−2007          Consultant
                   Pfizer Safety and Risk Management, New London, CT
                   Responsibilities included:
                   • Authoring Epidemiology Sections of Risk Management Plans
                   • Designing epidemiologic drug safety studies using the General
                       Practice Research Database, Clinical Trial Data, and other data
                       sources.
                   • Contributing to Risk Management Strategy
                   • Contributing to large systematic literature reviews and reporting
                   • Contributing to regulatory responses
                   • Data analysis and simulation
                   • Attending global epidemiology meetings

2006               Per Diem Staff Pharmacist
                   Stop and Shop Pharmacy, Rhode Island

2005−2006          Research Fellow in Pharmacoepidemiology and Therapeutic Risk
                   Management
                   Pfizer Inc
                   New London, CT, USA

2004−2005          Floating Staff Pharmacist
                   Brooks-Eckerd Pharmacy, Rhode Island

2003−2004          PharmD Clinical Clerkships
                   University of Rhode Island College of Pharmacy

                   •   Completed Six Clerkships in:
                         o Pharmacoepidemiology
                         o Community Practice
                         o Palliative and End-of-Life Care
                         o Psychiatry
                         o General Internal Medicine
                         o Managed Care




Updated May 2010                                                           Page 2 of 9
2000−2004             Pharmacy Intern
                      Rite Aid Pharmacy, Exeter, NH

2002−2003             Pharmacy Intern
                      Brooks Pharmacy, Warwick, RI

2001−2003             Managed Care and Clinical Pharmacy Intern
                      Advanced Pharmacy Concepts, North Kingstown, RI

2000                  Inpatient Pharmacy Intern
                      New England Medical Center, Boston, MA


HONORS AND AWARDS

2010           Ingenix President’s Award Recipient

2006−present Annals of Internal Medicine Outstanding Reviewer Recognition
             Reviews graded by editors as in top 10% (2009) of all reviews

2004           Rhode Island Pharmacists Association Student Service Award

2004           American Pharmacists Association Mortar and Pestle Professionalism Award

2004           University of Rhode Island College of Pharmacy Excellence in Research
               Award

2004           Kappa Psi Pharmaceutical Fraternity Brother of the Year Award

2002           Kappa Psi Pharmaceutical Fraternity Scholarship Honors

2001           Appointed Candidate for National Office of the Kappa Psi Pharmaceutical
               Fraternity

2000           Rho Chi Society Award

1999           Phi Eta Sigma National Honor Society Membership

1999           National Society of Collegiate Scholars Membership

1998−2004      University of Rhode Island Dean’s List

1998−2004      University of Rhode Island Centennial Scholarship Recipient


SELECTED RESEARCH ACTIVITIES

2007−present Since 2007, I have led several post-approval pharmacoepidemiologic safety
             studies of drugs and vaccines. Nearly all of my work has been based in
             commercial health insurance claims data and supplemented with information



Updated May 2010                                                               Page 3 of 9
               from abstracted medical records. Two common themes in this work have
               been the use of advanced techniques to mitigate confounding (e.g.
               propensity scores) and misclassification bias (e.g. application of data
               collected from outside the main study data source). Most of my research has
               been in collaboration with industry clients, and in the case of 2 projects, I was
               tasked with coordination of other research groups, requiring the development
               of study designs that allowed pooling of aggregate-level data across sites to
               preserve patient confidentiality.

2006−2008      Risks of Drug Therapy in the Elderly
               Data Source: Medicaid Analytic eXtract (MAX), Brown Medical School

2006−2007      Veterans Administration Topical Tretinoin Chemoprevention Trial
               PI: Martin Weinstock, MD, PhD, Providence Veterans Affairs Medical Center

2005−2006      Research Assistant, Pfizer Safety and Risk Management
               Data sources: various, Mentor: Annlouise R. Assaf, PhD, Brown Medical
               School

2006           Impact of Changing Medicaid Policies on Nursing Home Quality. Data
               source: Survey; Minimum Data Set; Medicare Claims; Online Survey,
               Certification and Reporting (OSCAR) PI: Vincent Mor, PhD, Brown Medical
               School

2002−2004      Electrocardiographic and Blood Pressure Effects of the Ephedra Containing
               TrimSpa Thermogenic Herbal Compound in Healthy Volunteers: a
               randomized, placebo-controlled crossover trial. PI: Michael F. Caron,
               PharmD, University of Rhode Island


TEACHING EXPERIENCE

Didactic

2009−present Lead Instructor: “Pharmacoepidemiology,” a semester-long course aimed at
             clinicians and doctoral students in epidemiology and health services research
             covering advanced topics related to studying outcomes of medical
             interventions.
             Program in Public Health, Brown Medical School

2008−present Section Leader: Biol 3650 C IMS-II, “Epidemiology/Quantitative Reasoning”
             1st year medical curriculum, Brown Medical School

2007           Guest Lecturer: PPH2410C “Pharmacoepidemiology”
               Program in Public Health, Brown Medical School

2006−2007      Guest Lecturer: PPPI1700K “Health Policy Challenges”
               Department of Public Policy, Brown University

2005           Teaching Certificate I



Updated May 2010                                                                  Page 4 of 9
               Brown University Sheridan Center for Teaching and Learning in Higher
               Education
               Awarded after participation in the Sheridan Teaching Seminar lectures and
               workshops, participation in a departmental micro-teaching session,
               completion of an individual teaching consultation, and submission of a formal
               summary evaluation

2004           Teaching Assistant: “The Burden of Disease in Developing Countries”
               Instructor: Stephen T. McGarvey, PhD, MPH, Brown University


Thesis Committees

2009−present Committee Member, Shirley Wang, PhD candidate (epidemiology).
             “Evaluating the role of antipsychotic use as a trigger for ischemic stroke:
             Application and extension of self-controlled designs.” Department of
             Community Health, Brown University


PROFESSIONAL LICENSE

2004−present Registered Pharmacist, Rhode Island (RPH04437)


PROFESSIONAL AFFILIATIONS AND SERVICE

2007           Proposal Reviewer: Health, Welfare, and Food Bureau. The People’s
               Republic of China (Hong Kong Administrative Region).

2006−2007      Member, American Public Health Association

2006−2008      Member, AcademyHealth

2005−present Member, International Society for Pharmacoepidemiology (ISPE);
             Development Committee (2007-Present); 25th Anniversary Committee (2008-
             Present); Local Host Committee for ICPE 2009 (2008-Present); Abstract
             Reviewer (2008-Present)

2005−2006      Graduate Program Steering Committee, Brown Medical School

2004−present Member, Kappa Psi Pharmaceutical Fraternity Graduate Chapter,
             Providence, RI

2003−2004      Vice-President, Phi Lambda Sigma Pharmacy Leadership Society

2002−2004      Member, American Society of Health Systems Pharmacists (ASHP)

2001−2003      Delegate, Collegiate Development Committee of the National Kappa Psi
               Pharmaceutical Fraternity, Inc.




Updated May 2010                                                                Page 5 of 9
2000−2004      College of Pharmacy Curriculum Committee, University of Rhode Island

1998−2004      Regent (President) (2000-2001), Chaplain (1999-2000), and Pledge
               Coordinator (2001-2002), Beta Epsilon Chapter, Kappa Psi Pharmaceutical
               Fraternity, Inc.


PEER REVIEWER

Journal of Diabetes Science and Technology
Movement Disorders
Clinical Therapeutics
Annals of Internal Medicine
Archives of Internal Medicine
Journal of Managed Care Pharmacy
American Journal of Geriatric Pharmacotherapy
Annals of Pharmacotherapy
the Journal of Pharmacy Technology


REFEREED PUBLICATIONS

Dore DD, Norman H, Loughlin J, Seeger JD. Extended Case-Control Study Results on
Thromboembolic Outcomes among Transdermal Contraceptive Users. Contraception.
2010;81(5):408-13.

Dore DD, Trivedi AN, Mor V, Friedman JH, Lapane KL. Atypical Antipsychotic Use and Risk
of Fracture in Persons with Parkinson’s Disease. Movement Disorders. 2009;24(13):1941-8

Dore DD, Trivedi AN, Mor V, Lapane KL. Association Between Extent of Thiazolidinedione
Exposure and Risk of Acute Myocardial Infarction. Pharmacotherapy. 2009;29(7):775-83

Dosa DM, Dore DD, Mor V, Teno JM. Frequency of Long-Acting Opioid Analgesic Initiation
in Opioid-Naïve Nursing Home Residents. Journal of Pain and Symptom Management.
2009;38(4):515-21

Daiello L, Ott, B, Lapane KL, Reinert S, Machan JT, Dore DD. Effect of discontinuing
cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients
with dementia. American Journal of Geriatric Pharmacotherapy. 2009;7(2):74-83

Dore DD, Seeger JD, Chan KA. Use of a Claims-Based Active Drug Safety Surveillance
System to Assess the Risk of Acute Pancreatitis with Exenatide or Sitagliptin Compared to
Metformin or Glyburide. Current Medical Research and Opinion. 2009;25(4):1019-1027

Dore DD, Lapane KL, Trivedi AN, Mor V, Weinstock MA. Association between statin use
and risk for keratinocyte carcinoma in the veterans affairs topical tretinoin chemoprevention
trial. Annals of Internal Medicine. 2009;150(1):9-18

Lapane KL, Quilliam BJ, Dore DD. Roadblock on the Health IT Superhighway: E-
Prescribing and the Controlled Substances Act. Journal of Opioid Management.
2007;3(4):181-4


Updated May 2010                                                                Page 6 of 9
Dore DD, DiBello JR, Lapane KL. Telithromycin Use and Spontaneous Reports of
Hepatotoxicity. Drug Safety 2007;30(8):697-703

Caron MF, Dore DD, Min B, Kluger J, Boguk I, White CM. The Electrocardiographic and
Blood Pressure Effects of the Ephedra Containing TrimSpa Thermogenic Herbal Compound
in Healthy Volunteers. Pharmacotherapy 2006;26(9):1241-6

Dore DD, Larrat EP, Vogenberg FR, Principles of Epidemiology for Clinical and Formulary
Management Professionals. Pharmacy and Therapeutics 2006;31(4):218-229


LETTERS

Dore DD, Norman H, Seeger JD. Eligibility Criteria in Venous Thromboembolism,
Myocardial Infarction, and Stroke Among Transdermal Contraceptive System Users.
Obstetrics & Gynecology, 2009;114(1):175.

Dore DD, Zierler S. Over-Reliance on Patient Information Sheets. American Journal of
Medicine, 2007;120(8):e3.


ABSTRACTS AND PRESENTATIONS

2009           Dore DD, Bloomgren GL, Patterson RE, Quinn SG, Hoffman C, Chaudhry S,
               Noel RA, Braun DK, Seeger JD. Incidence of Acute Pancreatitis in Exenatide
               Initiators Compared to Other Antidiabetic Drug Initiators: A Retrospective
               Cohort Study. International Society for Pharmacoepidemiology Annual
               Meeting (Oral). Providence, RI

2009           Dore DD, Seeger JD, Chan KA. Active Safety Surveillance of the Risk of
               Acute Pancreatitis Associated with Exenatide or Sitagliptin Compared to
               Metformin or Glyburide. International Society for Pharmacoepidemiology
               Annual Meeting (Poster). Providence, RI

2009           Dore DD, Chaudhry S, Quinn SG, Seeger JD. Medical Record Abstraction to
               Supplement Covariate Data in Health Insurance Claims: the Case of
               Diabetes and Acute Pancreatitis. International Society for
               Pharmacoepidemiology Annual Meeting (Poster). Providence, RI

2009           Dore DD, Hoffman C, Quinn SG, Chaudhry S, Seeger JD. Positive Predictive
               Value of Commercial Health Insurance Claims Data for Identifying Acute
               Pancreatitis in Patients with Diabetes Mellitus. International Society for
               Pharmacoepidemiology Annual Meeting (Oral). Providence, RI

2009           Dore DD, Norman H, Hoffman C, Wong J, Seeger JD. Extended Results on
               the Risk of Venous Thromboembolism, Myocardial Infarction, and Stroke in
               Users of Transdermal Norelgestromin/Ethinyl Estradiol. International Society
               for Pharmacoepidemiology Annual Meeting (Oral). Providence, RI




Updated May 2010                                                              Page 7 of 9
2009           Dore DD, McAfee AT, Woo RK, Seeger JD. Enhanced Oncology Applications
               of Health Insurance Claims Data through Clinical Data Linkage. International
               Society for Pharmacoepidemiology Annual Meeting (Poster). Providence, RI

2009           Bloomgren GL, Dore DD, Patterson RE, Noel RA, Braun DK, Seeger JD.
               Incidence of Acute Pancreatitis in Exenatide Initiators Compared to Other
               Antidiabetic Drug Initiators: A Retrospective Cohort Study. (Oral; presented
               by Dr. Bloomgren) American Diabetes Association Annual Scientific Meeting.
               New Orleans, LA

2008           Dore DD, Trivedi AN, Mor V, Friedman JH, Lapane KL. Atypical Antipsychotic
               Use and Risk of Fracture in Persons with Parkinson’s Disease (Oral
               Presentation). International Society for Pharmacoepidemiology Annual
               Meeting (Oral). Copenhagen, Denmark

2008           Dore DD, Trivedi AN, Mor V, Lapane KL. Timing of Thiazolidinedione
               Initiation and Risk of Acute Myocardial Infarction (Poster). International
               Society for Pharmacoepidemiology Annual Meeting (Poster). Copenhagen,
               Denmark

2008           Dore DD, Loughlin J, Jones M, Zhu S, Chaudhry SB, Seeger JD. Risk of
               Ventricular Arrhythmia in Association with Atomoxetine Use in Adults.
               International Society for Pharmacoepidemiology Annual Meeting (Poster).
               Copenhagen, Denmark

2008           Dore DD. Benefits and Consequences of Drug Therapy in the Elderly.
               Dissertation Defense. Brown Medical School, Providence, RI

2007           Dore DD, Lapane KL, Mor V, Trivedi AN, Weinstock MA. Effectiveness of
               Statins for Prevention of Keratinocyte Carcinomas (Oral Presentation).
               International Society for Pharmacoepidemiology Annual Meeting. Quebec
               City, Quebec, Canada

2007           Dore DD. An overview of the Medicaid Analytic eXtract (Research Seminar).
               Center for Gerontology and Health Care Research, Brown Medical School

2007           Dore DD, Lapane KL. Prevalence and Correlates of Stimulant Medication
               Use in U.S. Adults (Poster). AcademyHealth Annual Research Meeting.
               Orlando, FL

2007           Dore DD, Dosa DM, Mor V, Teno JM. Potentially Inappropriate Initiation of
               Long-Acting Narcotic Analgesics in Nursing Home Residents (Poster).
               Agency for Health Care Research and Quality Fellows Meeting. Orlando, FL

2007           Dore DD. Effectiveness of Statins for Prevention of Keratinocyte Carcinoma
               (Research Seminar). Center for Gerontology and Health Care Research,
               Brown Medical School

2006           Dore DD, DiBello JR, Lapane KL. Evaluating Telithromycin-Related
               Hepatotoxicity: An Application of the Case-Control Design to Spontaneous



Updated May 2010                                                              Page 8 of 9
               Report Data (Poster). International Society for Pharmacoepidemiology
               Annual Meeting. Lisbon, Portugal

2006           Dore DD. Prevalence and Determinants of Atypical Antipsychotic Use in
               Nursing Homes (Oral Presentation). Agency for Health Care Research and
               Quality Fellows Meeting. Seattle, WA

2005           Dore DD. Navigating Medicare Part D: An Impossible Dream? Center for
               Gerontology and Health Care Research, Brown Medical School

2005           Kogut SK, Dore DD. Alzheimer’s Disease, a focus on medical therapy.
               Presented to community members and the Cranston Senior Center,
               Cranston, RI (Community Outreach)

2004           Dore DD, Boguk I, Caron MF. What are the Effects of a Dietary Weight Loss
               Supplement Containing Ephedrine and Caffeine on Heart Rate and QT
               Interval in Healthy Volunteers (Poster)? American Society of Health-System
               Pharmacists Annual Meeting, Las Vegas, NV

2004           Dore DD, Bunz TJ, Kogut SJ. Drug therapy for Alzheimer’s disease:
               Persistence on Cholinesterase Inhibitors Measured using Medicaid Pharmacy
               Claims Data (Oral Presentation). American Pharmacists Association Annual
               Meeting, Seattle, WA

2004           Bunz TJ, Dore DD, Kogut SJ. Persistence after cholinesterase therapy
               change in a Medicaid dataset (Poster). American Pharmacists Association
               Annual Meeting, Seattle, WA

2003           Dore DD, Responsible use of Medications at the End of Life. Home and
               Hospice Care of Rhode Island, Pawtucket, RI

2003           Dore DD, The Role of Atypical Antipsychotics in the Management of
               Dementia. Home and Hospice Care of Rhode Island, Pawtucket, RI

2003           Dore DD, Bunz TJ. The Influence of Concomitant use of Anticholinergics on
               Persistence with Cholinesterase Inhibitors in Alzheimer’s Disease. Graduate
               Seminar in Pharmacoepidemiology and Pharmacoeconomics; University of
               Rhode Island College of Pharmacy, Kingston, RI

2003           Dore DD, Vivenzio J. Understanding Drug Costs. Riverwoods Retirement
               Community, Exeter, NH (Community Outreach)




Updated May 2010                                                              Page 9 of 9

								
To top